Alzheimer research

Case Western Reserve Researchers Discover FDA-approved Drug Rapidly Clears Amyloid from the Brain and Reverses Cognitive and Memory Defects. School of Medicine Neurosciences Gary Landreth, PhD Paige Cramer

Length: 00:01:27.750
Tags: 2012 research report alzheimers h264 .

How many times have you lost your car keys? Or forgotten someone's name? We all have memory loss. It's a normal part of aging. But researchers at Mayo Clinic found that if you carry a gene known to increase the risk of Alzheimer's disease, your memory may decline faster than people without the gene, even if you never develop full blown Alzheimer's.

Length: 00:01:46.500
Tags: .

A brief overview of Alzheimer's disease research. Alzheimer's disease is the leading cause of irreversible dementia in the United States. Currently, there is no cure. Information about the scientific research funded by AHAF is online at www.ahaf.org/research/grants. To receive e-alerts about new research findings in the field of Alzheimer's disease, click here: www.ahaf.org/join.

Length: 00:00:59.250
Tags: Alzheimer's disease Alzheimer's dementia research brain health neurology .

Watch this video featuring a top Alzheimer researcher. He addresses many of the basic questions that are key to understanding this challenging disease. Learn More About Alzheimer's Disease Research, What's Being Done.

Length: 00:01:33
Tags: Alzheimer's Medicines Discovery Medical Innovation phrma Researchers Plaque Cells Baby Boomers Healthcare language:en .

The Fisher Center lab is headed by Dr. Paul Greengard, winner of a Nobel Prize in 2000 for his pioneering work in delineating how neurons communicate with one another in the brain. Dr. Paul Greengard and his team of over 50 internationally renowned scientists are determined to defeat Alzheimer's disease. They have greatly accelerated the pace of research through a new technology they developed that is capable of analyzing thousands of brain cells at once, instead of previously -- one at a time.

Length: 00:01:08.250
Tags: donate .

Since the inception of the Alzheimer's Research and Prevention Foundation in 1993, the focus has always been about prevention. In today's world, this concept is more relevant than ever before, as we are witnessing the medical community embrace the need for this approach. In fact, Alzheimer's disease is associated with more deaths in the United States than any other disease, and will soon be for the entire world as well. Dharma Singh Khalsa, MD, founding president and medical director of the Alzheimer's Research and Prevention Foundation, recently sat down to discuss some exciting developments in the Alzheimer's research field and talks about the vindication of the science behind the ARPF's work in the prevention field and the promise it holds.

Length: 00:04:28.500
Tags: introduction health alzheimer's disease .

Jeanne Little's daughter, Katie, talks to Today Tonight about her mother's illness and the launch of the Jeanne Little Alzheimer's Research Fund at Neuroscience Research Australia.

Length: 00:05:45.750
Tags: Today Tonight .

It was believed that Alzheimer's disease results when a particular protein randomly detaches itself from brain cells, which are usually connected, and to form tangles. It was thought this happened in many parts of the brain at the same time. But, new research is challenging this view. The latest research on the subject suggests the protein actually spreads cell by cell through the brain in a predictable way. The new findings are an important step in the battle against the disease. Al Jazeera's Tarek Bazley reports.

Length: 00:01:49.500
Tags: youtube Tarek Bazley aljazeera .

Viewer advisory: This video depicts an actual medical procedure. Hypodermic needles and blood are shown.

Length: 00:05:10.500
Tags: University of Kentucky video Alzheimer's disease Alzheimer's research UK research spinal fluid medicine science .

(Part 1 of 4) Robert Klein, JD and Leeza Gibbons, gave the welcoming remarks for the "Spotlight on Alzheimer's Disease," an educational event presented at the CIRM Governing Board meeting on December 10, 2008. Klein is Chair of the CIRM Governing Board and President of Klein Financial Corporation. Gibbons is a patient advocate member of the CIRM Governing Board and is the founder of the Leeza Gibbons Memory Foundation. The CIRM-hosted event was presented in partnership with the University of California, Irvine at the UC Irvine Student Center.

Length: 00:08:33.750
Tags: california institute regenerative medicine prop proposition CIRM irvine university gibbons .

Donate at: www.alzheimerbc.org

Length: 00:00:23.250
Tags: .

(Part 3 of 4) Rodman Shankle, MD spoke at the "Spotlight on Alzheimer's disease", an educational event presented at the CIRM Governing Board meeting on December 10, 2008. Shankle reviewed clinical data, which indicates that stem cells from the fat pad of the intestines have the capacity to repair damaged brain tissue found in Alzheimer's disease and other neurological disorders. Shankle is the founder and medical director of the Shankle Clinic for Alzheimer's Disease and Related Disorders. He is also Chief Medical Officer of the Medical Care Corporation.

Length: 00:13:47.250
Tags: california institute regenerative medicine prop proposition CIRM clinic .

Breakthrough research that helps victims of Parkinson's and Alzheimer's diseases is happening at the Technion. Prof. Moussa Youdim and his team are already known for their discovery of Azilect, an anti-Parkinson's drug that has been approved by the FDA. Their work continues to help develop drugs that may in the future not only treat these diseases but reverse their effects. The American Technion Society supports the work of Prof. Youdim and other researchers who are helping people lead better and healthier lives.

Length: 00:03:20.250
Tags: Alzheimer's Parkinson's Technion .

Just a simple intro to who we are and where we are going as a folding team.... IF YOU have a ps3 or a PC, please join us to find the cure for Cancer, Alzheimer's, Parkinson's and Huntington's disease. Ask me if you have any questions at all... ITS MUCH simpler than you think ! Google "folding@home" to read more about this powerful medical tool.

Length: 00:03:27.750
Tags: .

Alzheimer's Disease is a devastating illness that is on the rise in Canada. McGill's world-renowned researchers, including Rémi Quirion, Judes Poirier, and Serge Gauthier, are making major advances in our understanding and treatment of Alzheimer's.

Length: 00:09:48
Tags: .

Professor Mara Dierssen, Group Leader at the Centre for Genomic Regulation, Barcelona (Spain). Her laboratory is investigating specific links between cognitive impairments and memory disorders in patients with Down syndrome and behavioural deficits in mouse models of this disease. She has published a number of peer reviewed papers on the subject. Translational research in Down's syndrome: from understanding neurobiology to therapies that improve memory and brain function Mara Dierssen Center for Genomic Regulation (CRG) and CIBERER, Barcelona, Spain Down syndrome (DS) is the most common genetic cause of mental retardation. Mental retardation is a developmental disability with onset during childhood characterized by significant impairment of intellectual functioning and adaptive skills causing major limitations to live a normal, independent life. During many years DS has been considered a hopeless disorder. However, recent advances in the knowledge of DS neurobiology have led to crucial discoveries opening the possibility to therapy. However, an abundance of inconclusive study findings and contradictory information has made it difficult for parents who want definitive answers from credible sources. The main problems in the field have been over-reliance on a few pharmacological mechanisms, lack of validated molecular targets, and the severe side effects and narrow dose window of some of the proposed drugs. Moreover, in most, if not all the cases, the disease progression and ...

Length: 00:18:54.750
Tags: .

The Search for Medicine for Down's Syndrome Towards an International Research Alliance September 17th 2011 The Wellcome Trust Conference Centre Genome Campus Hinxton, Cambridge, UK. Program sponsored by The Down's Syndrome Research Foundation UK www.dsrf-uk.org and a grant from Alzheimer's Research UK www.alzheimersresearchuk.org Jacqueline London professor at the Paris-Diderot university. She founded 21 years ago a French Association for Research on Trisomy 21 (AFRT) with a publication "News from chromosome 21". She is a Board member of European Down's Syndrome Association (EDSA). Her research is devoted to mouse models for Down syndrome especially in relation to oxidative stress, homocystein metabolism, aging and some side characteristics of persons with trisomy 21 (skin, hair and sleep manifestations). Therapeutical Approach for Common clinical aspects in Trisomy 21 and Alzheimer disease University Denis-Diderot,35 rue Hélène Brion, 75205 Paris Cedex 13, France Although it is well reported that patients with Down syndrome (DS) are at high risk to develop the Alzheimer's type dementia by 50 years, it is known that not all of them will develop the dementia and very few drugs used for Alzheimer patients have been evaluated in adults with Down syndrome to prevent dementia.These drugs have been or will be evaluated to treat the cognitive impairment in children or young adults with DS and so far there are only some pilot studies (memantine, PTZ, L-DOPS, folinic acid) but in ...

Length: 00:13:24.750
Tags: Jacqueline London Professor Translational .

www.alzheimers.org.uk This film explains and defines what dementia is, and how it affects the brain. TRANSCRIPT "Dementia affects over 750000 people in the UK. It is not a disease in its own right and it is not a natural part of ageing. It is an umbrella term that describes a large group of symptoms that are caused by diseases that affect the brain, such as Alzheimer's disease. Dementia is caused by a loss of nerve cells in the brain. It is a progressive condition, meaning that it gradually gets worse. This is because when a nerve cell dies it cannot usually be replaced. As more and more cells die the brain starts to shrink. This is known as brain atrophy, which can sometimes be seen in a brain scan of someone in the later stages of dementia. Common symptoms of dementia include memory loss, impaired cognition and loss of physical coordination. However, the symptoms depend on the area of the brain that is affected. For example, if nerve cells in the temporal lobe start to die, that person may start to have difficulties in their language, while nerve cell death in the occipital lobe, at the back of the brain, can cause problems with vision. Sadly there is currently no cure for dementia and many of the diseases that cause it are terminal. The cerebellum and brain stem control our basic life functions. If cells die in these areas, the body will start to shut down." Please watch our other videos to see how brain cells function, hear what dementia is, and to hear more about ...

Length: 00:01:12.750
Tags: .

www.alzheimers.org.uk This film looks at what happens to a brain with Alzheimer's disease, including the development of amyloid plaques and tau tangles. Alzheimer's disease is the most common form of dementia. TRANSCRIPT Alzheimer's disease affects over 400000 people in the UK. It is the most common cause of dementia, and also the best understood. The hallmarks of Alzheimer's disease are the formation of plaques and tangles in the brain. These structures are made up from two key proteins, amyloid and tau. Amyloid is produced when a much larger protein, the amyloid precursor protein, is degraded. In healthy cells amyloid is removed. However, during Alzheimer's disease the amyloid accumulates on the outside of nerve cells forming plaques. Scientists think that amyloid is toxic to cells. The second protein involved in Alzheimer's disease is called tau. In healthy cells tau is an important part of the internal cell network, helping to transport nutrients around the cell. However, during Alzheimer's disease an abnormal version of tau is produced. This abnormal tau does not function correctly. It forms tangles inside the cells, disrupting the transport network and effectively strangling the cell. The current treatments for Alzheimer's disease are designed to improve communication between cells. However, they can only slow the progression of the disease. Scientists hope that a future drug will target amyloid or tau and stop the disease altogether." Please watch our other videos ...

Length: 00:01:12.750
Tags: .

www.alzheimers.org.uk This film gives a overview of the structure and function of the brain. TRANSCRIPT "The human brain is incredibly complex. It controls everything our body does, from coordinating our movements and our speech, to keeping our heart beating, to storing our memories. Despite all this there is still a lot we don't know and much of the brain's inner workings are still a mystery. The average human brain weighs around 1.5 kg. It is fed by a network of blood vessels that provide the brain cells with oxygen and nutrients. The brain can be divided into four main sections - the cerebral cortex, which is split into two symmetrical cerebral hemispheres, the limbic system, the cerebellum and the brain stem. The bulk of the brain is the symmetrical cerebral cortex. Each cerebral hemisphere is separated into four main lobes, which have different functions. The frontal lobe is responsible for decision-making, problem solving and planning. The parietal lobe receives and processes all the sensory information from the body. The temporal lobe is responsible for memory, emotion, hearing and language. The occipital lobe controls vision. At the centre of the brain is the limbic system. This area controls a number of functions, but importantly controls learning and memory, particularly in the hippocampus. The cerebellum or little brain, controls movement, posture and balance. The brain stem, which is thought to be the oldest part of the brain, controls basic life functions ...

Length: 00:01:21.750
Tags: .